U.S. Fixed And Mobile C-arms Market Size, Share & Trends Analysis Report By Product (Fixed C-arms, Mobile C-arms), By Application (Orthopedics And Trauma, Neurosurgery, Cardiovascular), By Country, And Segment Forecasts, 2025 - 2030

Market Size & Trends

The U.S. fixed and mobile C-arms market size was estimated at USD 761.1 million in 2024 and is expected to expand at a CAGR of 3.78% from 2025 to 2030. Major factors contributing to the U.S. fixed and mobile C-arms industry include the increasing prevalence of chronic diseases such as cardiovascular disorders, orthopedic conditions, and cancer, which drive the demand for minimally invasive surgical procedures where C-arms play a vital role in intraoperative imaging. In addition, technological advancements and the expanding geriatric population-more susceptible to age-related conditions requiring surgical interventions-further fuel market growth. According to the Centers for Disease Control and Prevention (CDC), in the U.S., one person dies from cardiovascular disease every 33 seconds, with a total of 702,880 deaths recorded in 2022, which is equivalent to one in every five deaths.

The growth of the U.S. C-arms market is primarily driven by increasing demand for minimally invasive procedures across various medical specialties, including orthopedics, cardiology, and pain management. C-arms, which provide real-time fluoroscopic imaging during surgical procedures, have become essential for precision-guided treatments. The rising prevalence of chronic diseases such as osteoporosis and cardiovascular conditions has led to a higher volume of surgeries requiring intraoperative imaging. In addition, the shift toward outpatient and ambulatory surgery centers (ASCs) has increased demand for mobile C-arms, as these facilities require compact, high-performing imaging solutions that enhance procedural efficiency.

Moreover, the technological advancements in the C-arm systems, owing to the increasing focus of market players to develop advanced products, further contribute to market growth. For instance, in February 2024, Philips introduced the Zenition 90 Motorized, an advanced mobile C-arm system designed to enhance image-guided therapy. This system offers surgeons table-side control, automated workflows, and superior imaging quality, catering to complex procedures such as cardiac interventions and urology. Such advancements significantly increase the adoption of C-arms in various healthcare settings in the country and address the demand for advanced C-arms systems, thereby fueling the market growth.

Market Concentration & Characteristics

The industry growth stage is moderate, and the pace of the growth is accelerating. The U.S. fixed and mobile C-arms industry is characterized by a low to moderate degree of growth. Key driving factors include the increasing prevalence of cardiovascular and chronic disorders, technological advancements in C-arm systems, growing geriatric population, and the increasing adoption by various healthcare facilities, including outpatient surgical centers and ambulatory surgical centers in the country.

The degree of innovation in the U.S. fixed and mobile C-arms industry constantly evolves due to the constant advancements in medical technology and a competitive healthcare landscape. The demand for more precise and efficient imaging systems drives manufacturers to innovate features such as enhanced image quality, portability, and lower radiation exposure. For instance, in March 2024, Siemens Healthineers launched Ciartic Move, a self-driving, automated C-arm system for intraoperative imaging. It allows precise, remote-controlled positioning, saving up to 50% of the time in procedures such as spine and pelvic surgeries. The system reduces the burden on staff, improves workflow, and reduces imaging times, enhancing efficiency in the operating room.

The U.S. fixed and mobile C-arms industry is witnessing a significantly high level of partnerships and collaboration. Partnerships and collaborations allow industry players to increase their presence and address the increasing demand for C-arms. For instance, in April 2021, Ziehm Imaging Americas and Carestream Health partnered to distribute the Ziehm Vision RFD mobile C-arm in the U.S. and Canada. This system enhances Carestream's portfolio with advanced imaging capabilities for various surgical applications, improved cooling, and reduced radiation exposure through SmartDose technology.

Regulatory framework for the U.S. fixed and mobile C-arms industry falls under the FDA's Center for Devices and Radiological Health (CDRH). Manufacturers need to obtain FDA clearance, typically through the 510(k) premarket notification process, ensuring their devices comply with stringent radiation safety standards, including limits established by the National Council on Radiation Protection and Measurements (NCRP). Post-market surveillance and adherence to quality control standards are mandatory, while certain advanced models also require FDA approval under the Premarket Approval (PMA) process.

The threat of substitutes in the U.S. fixed and mobile C-arms industry comes from alternatives such as portable ultrasound systems, MRI machines, and robotic-assisted surgical systems. These technologies can sometimes replace the need for traditional X-ray imaging in certain procedures. However, C-arms maintain an edge due to their versatility, real-time imaging, and cost-effectiveness in orthopedics, trauma care, and other surgical fields. Their compact design and mobility in mobile models also make them preferred in settings with space or budget constraints.

The industry players are focusing on increasing their presence in the country to address the rising demand for C-arms and establish a presence. Various strategies, such as distribution agreements, are adopted by companies to increase their distribution network. For instance, in June 2023, GE HealthCare announced partnership with DePuy Synthes, a part of Johnson & Johnson, to bring its OEC 3D Imaging System to spine surgeons across the U.S. This distribution agreement combines GE’s advanced imaging technology with DePuy’s extensive spine product portfolio, aiming to enhance surgical precision and improve patient care.

Product Insights

Fixed arms held the largest share of 57.95% in 2024 owing to their better performance, stability, and versatility in clinical settings. These systems are designed for high-demand procedures and environments such as operating rooms and interventional suites, where consistent, high-quality imaging is required. The stationary nature of fixed C-arms ensures better stability during imaging, reducing motion and providing clearer, more precise images compared. Furthermore, the integration capabilities of fixed C-arms with other medical technologies, such as electronic health records (EHR) systems and surgical navigation tools, contribute to their dominance in the market.

Mobile C-arms are expected to grow at the highest CAGR of 4.66% over the forecast period due to their enhanced flexibility and ability to provide high-quality imaging in diverse clinical settings. Furthermore, technological advancements in mobile C-arms are contributing to their rapid adoption in the U.S. market. In addition, innovations such as wireless connectivity, self-driving C-arms, and more intuitive user interfaces have made mobile C-arms easier to operate, making them a valuable tool for a range of specialties, including orthopedics, cardiology, and neurology. For instance, in March 2024, Siemens Healthineers announced FDA clearance for its CIARTIC Move, a self-driving mobile C-arm that automates intraoperative imaging workflows. It improves efficiency by reducing repositioning time in surgeries such as orthopedics and spine procedures. The device can store positions, automate imaging, and be remotely controlled, addressing staff shortages and workflow challenges. Such innovations are further expected to fuel the segment growth over the forecast period.

Application Insights

Orthopedics and trauma held the largest share of 26.35% in 2024. In orthopedics, C-arms provide real-time, high-resolution imaging during joint replacement surgeries, fracture repairs, and spinal surgeries. In addition, C-arms are essential for imaging soft tissue and bone structures, helping surgeons assess the extent of damage in conditions such as arthritis, fractures, and deformities. According to the Centers for Disease Control and Prevention (CDC), in 2022, the prevalence of age-adjusted arthritis among adults aged 18 and older in the U.S. was 18.9%, with a prevalence rate higher in women of 21.5%, compared to 16.1% for men. Similarly, in trauma care, the use of C-arms has become crucial for emergency settings where rapid and accurate imaging is essential, further increasing their adoption.

Cardiovascular is expected to witness the fastest growth over the forecast period due to the increasing demand for advanced imaging technologies in cardiovascular procedures. With a rising prevalence of heart diseases, such as coronary artery disease and heart failure, healthcare providers are increasingly relying on C-arm imaging systems for real-time, high-resolution imaging during minimally invasive procedures. The aging population of the country, with a higher risk of cardiovascular diseases, further increases the demand. According to the Population Reference Bureau (PRB), the population of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050. As the number of cardiovascular procedures grows in response to an aging population and a higher incidence of risk factors such as obesity and diabetes, the demand for C-arms in this application is expected to increase over the forecast period.  

Key U.S. Fixed And Mobile C-arms Company Insights

The U.S. fixed and mobile C-arms market is highly competitive and has several key players. The companies operating in the market are adopting various strategies such as product launches, approvals, expansion, partnership and collaborations, mergers and acquisitions and others to increase their market presence. For instance, in June 2024, Philips' Zenition 90 Motorized mobile C-arm received FDA 510(k) clearance. This high-powered, motorized system enhances clinician control and efficiency during complex procedures, including cardiac interventions and urology. It features automated workflows and advanced imaging capabilities, supporting a wide range of clinical applications.

Recent Development

• In November 2024, GE HealthCare enhanced its OEC 3D mobile CBCT C-arm with new applications to improve imaging during endoscopic bronchoscopy. The OEC 3D Lung Suite offers augmented fluoroscopy and adjustable motorized 3D scanning, while the expanded OEC Open interface now integrates with systems such as Intuitive’s Endoluminal Robotic Bronchoscopy System, facilitating seamless data transfer for precise interventions.

• In July 2023, Radon Medical Imaging acquired Tristate Biomedical Solutions, expanding its biomedical and C-Arm offerings in Ohio, Kentucky, Indiana, and Louisiana. The acquisition aligns with Radon's strategy to strengthen its position in the medical imaging industry of the U.S.

• In July 2022, Siemens Healthineers' ARTIS icono ceiling, a ceiling-mounted C-arm angiography system, received FDA clearance. It offers rapid cone beam CT acquisitions, reducing motion artifacts and contrast media usage. The system's flexible design and intelligent workflows enhance interventional radiology and cardiology procedures.

• In March 2024, GE HealthCare and Hartford HealthCare renewed their collaboration through 2030. Hartford HealthCare planned to upgrade imaging technologies, including the OEC 3D surgical imaging C-arm, to enhance patient care with advanced AI and software. This initiative aimed to reduce scan times and improve diagnostic accuracy.

U.S. Fixed And Mobile C-arms Market Report Scope

U.S. Fixed And Mobile C-arms Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. fixed and mobile C-arms market report based on product and application:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Fixed C-arms

  • Mobile C-arms

    • Full Size C-arms

    • Mini C-arms

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Orthopedics and Trauma

  • Neurosurgery

  • Cardiovascular

  • Pain Management

  • Gastroenterology

  • Others